Teladoc Health Reports Fourth-Quarter and Full-Year 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Teladoc (TDOC) Q4 Revenue Tops Views, Offers Guidance
February 24, 2021 4:08 PM ESTTeladoc (NYSE: TDOC) reported Q4 EPS of ($3.07), may not compare to the analyst estimate of ($0.24). Revenue for the quarter came in at $383.3 million versus the consensus estimate of $378.93 million.
GUIDANCE:
Teladoc sees Q1 2021 revenue of $445-455 million, versus the consensus of $446 million.
EBITDA to... More